investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
Alison P Klein
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Collaborator from Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
New York, United States
Steven Gallinger
Toronto General Hospital
Toronto, Canada
University Health Network
Toronto, Canada
Mount Sinai Hospital
Toronto, Canada
Rachel Neale
QIMR Berghofer Medical Research Institute
Brisbane, Australia
Eric Duell
Institut Català d'Oncologia
Barcelona, Spain
Paul Brennan
International Agency For Research On Cancer
Lyon, France
Alison P Klein
Johns Hopkins University
Baltimore, United States
Related projects
Milind Javle
Targeting the "BRCAness" Phenotype in Pancreas Cancer
Pancreas
Pathology
Gloria M Petersen
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment
Pancreas
Pathology
Masato Yamamoto
Next Generation Oncolytic Adenovirus for Advanced Pancreatic Cancer Treatment
Pancreas
Pathology
Jonathan Brody
Utilizing HuR to Optimize the Treatment of Pancreatic Cancer
Pancreas
Pathology
Donald J Buchsbaum
UAB / UMN SPORE in Pancreatic Cancer
Pancreas
Pathology
Keping Xie
Molecular Mediators of Pancreatic Cancer Invasion and Progression
Pancreas
Pathology
Denis C Guttridge
(PQD6) Muscle Stem Cells and Cancer Cachexia
Pancreas
Pathology
Keping Xie
Functional Validation of Pancreatic Cancer Progression Biomarker
Pancreas
Pathology
Aliye Uc
INSPPIRE to Study Pediatric Chronic Pancreatitis
Pancreas
Pathology
